Juvenile dermatomyositis. Pathophysiology and disease expression.
In summary, the child who develops the symptoms of the specific rash, proximal muscle weakness, or fatigue should seek medical care promptly. With the advances in physical and medical therapy, many of the consequences of the disease can now be ameliorated. Data suggest that JDMS and PM may each have a different pathophysiology, but more evidence is needed. The next few years will be exciting as there is a national effort by an increased number of investigators to determine the epidemiologic and genetic factors that influence JDMS disease susceptibility and severity.
Pachman
L M
LM
Department of Pediatrics, Northwestern University Medical School, Illinois, USA.
D002648:Child; D003882:Dermatomyositis / Q000175:diagnosis* / Q000209:etiology / Q000628:therapy; D003937:Diagnosis, Differential; D005260:Female; D006801:Humans; D008297:Male; D013256:Steroids / Q000627:therapeutic use
D013256:Steroids